These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 16368111)
1. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. Kim JW; Kim BN; Cho SC J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111 [TBL] [Abstract][Full Text] [Related]
2. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660 [TBL] [Abstract][Full Text] [Related]
3. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920 [TBL] [Abstract][Full Text] [Related]
4. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610 [TBL] [Abstract][Full Text] [Related]
5. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728 [TBL] [Abstract][Full Text] [Related]
6. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Kim YS; Leventhal BL; Kim SJ; Kim BN; Cheon KA; Yoo HJ; Kim SJ; Badner J; Cook EH Neurosci Lett; 2005 Dec; 390(3):176-81. PubMed ID: 16165273 [TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele. Ohadi M; Shirazi E; Tehranidoosti M; Moghimi N; Keikhaee MR; Ehssani S; Aghajani A; Najmabadi H Brain Res; 2006 Jul; 1101(1):1-4. PubMed ID: 16782077 [TBL] [Abstract][Full Text] [Related]
8. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. Becker K; El-Faddagh M; Schmidt MH; Esser G; Laucht M J Pediatr; 2008 Feb; 152(2):263-9. PubMed ID: 18206700 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]
10. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430 [TBL] [Abstract][Full Text] [Related]
11. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP. Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946 [TBL] [Abstract][Full Text] [Related]
12. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Neuman RJ; Lobos E; Reich W; Henderson CA; Sun LW; Todd RD Biol Psychiatry; 2007 Jun; 61(12):1320-8. PubMed ID: 17157268 [TBL] [Abstract][Full Text] [Related]
13. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Manor I; Tyano S; Mel E; Eisenberg J; Bachner-Melman R; Kotler M; Ebstein RP Mol Psychiatry; 2002; 7(6):626-32. PubMed ID: 12140786 [TBL] [Abstract][Full Text] [Related]
14. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile]. HenrĂquez B H; HenrĂquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827 [TBL] [Abstract][Full Text] [Related]
15. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder. Simsek M; Al-Sharbati M; Al-Adawi S; Ganguly SS; Lawatia K Clin Biochem; 2005 Aug; 38(8):739-42. PubMed ID: 15993876 [TBL] [Abstract][Full Text] [Related]
16. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan. Shang CY; Gau SS; Liu CM; Hwu HG Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641 [TBL] [Abstract][Full Text] [Related]
17. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4). Gizer IR; Waldman ID J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179 [TBL] [Abstract][Full Text] [Related]
18. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773 [TBL] [Abstract][Full Text] [Related]
19. Verbal but not performance IQ is highly correlated to externalizing behavior in boys with ADHD carrying both DRD4 and DAT1 risk genotypes. Kebir O; Grizenko N; Sengupta S; Joober R Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):939-44. PubMed ID: 19409950 [TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter genotype influences the physiological response to medication in ADHD. Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]